As of 2025-07-09, the Relative Valuation of AxoGen Inc (AXGN) is (5.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.48 USD, the upside of AxoGen Inc based on Relative Valuation is -147.5%.
The range of the Relative Valuation is (5.25) - (5.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.6x - 39.7x | 35.5x |
| Forward P/E multiples | 33.4x - 34.8x | 33.8x |
| Fair Price | (5.25) - (5.47) | (5.45) |
| Upside | -145.7% - -147.6% | -147.5% |
| Date | P/E |
| 2025-07-07 | -72.22 |
| 2025-07-03 | -69.49 |
| 2025-07-02 | -70.32 |
| 2025-07-01 | -69.68 |
| 2025-06-30 | -68.98 |
| 2025-06-27 | -66.76 |
| 2025-06-26 | -66.56 |
| 2025-06-25 | -65.17 |
| 2025-06-24 | -64.53 |
| 2025-06-23 | -62.24 |
| 2025-06-20 | -61.86 |
| 2025-06-18 | -59.06 |
| 2025-06-17 | -60.59 |
| 2025-06-16 | -61.99 |
| 2025-06-13 | -61.99 |
| 2025-06-12 | -63.83 |
| 2025-06-11 | -64.66 |
| 2025-06-10 | -67.90 |
| 2025-06-09 | -66.18 |
| 2025-06-06 | -69.43 |
| 2025-06-05 | -68.66 |
| 2025-06-04 | -69.30 |
| 2025-06-03 | -72.22 |
| 2025-06-02 | -69.74 |
| 2025-05-30 | -69.24 |
| 2025-05-29 | -69.30 |
| 2025-05-28 | -69.68 |
| 2025-05-27 | -71.84 |
| 2025-05-23 | -70.38 |
| 2025-05-22 | -69.55 |
| 2025-05-21 | -72.45 |
| 2025-05-20 | -73.56 |
| 2025-05-19 | -74.77 |
| 2025-05-16 | -75.21 |
| 2025-05-15 | -74.89 |
| 2025-05-14 | -75.15 |
| 2025-05-13 | -69.17 |
| 2025-05-12 | -72.41 |
| 2025-05-09 | -72.25 |
| 2025-05-08 | -80.04 |
| 2025-05-07 | -104.20 |
| 2025-05-06 | -104.33 |
| 2025-05-05 | -106.49 |
| 2025-05-02 | -108.91 |
| 2025-05-01 | -104.77 |
| 2025-04-30 | -103.44 |
| 2025-04-29 | -104.97 |
| 2025-04-28 | -102.87 |
| 2025-04-25 | -104.27 |
| 2025-04-24 | -102.74 |